首页 | 本学科首页   官方微博 | 高级检索  
检索        

淋巴瘤免疫化疗后急性肝炎再活动挽救性抗病毒治疗的临床观察
引用本文:董敏,魏丽,林曲,李星,温景芸,马小琨,陈展洪,吴祥元.淋巴瘤免疫化疗后急性肝炎再活动挽救性抗病毒治疗的临床观察[J].中华肿瘤防治杂志,2011,18(21):1717-1719.
作者姓名:董敏  魏丽  林曲  李星  温景芸  马小琨  陈展洪  吴祥元
作者单位:中山大学附属第三医院肿瘤内科,广东广州,510630
基金项目:广东省医学科学基金(A2010179)
摘    要:目的:初步分析挽救性抗病毒治疗对于淋巴瘤免疫化疗后急性肝炎再活动的价值。方法:回顾性分析19例经免疫化疗后出现急性肝炎再活动的淋巴瘤患者的临床特征、挽救性抗病毒治疗方案及治疗效果,使用受试者工作特征(ROC)及Kap-lan-Meier曲线分析病毒应答时间及不同抗病毒策略的价值。结果:在19例患者中,10例肝炎活动治愈,13例达到病毒应答,病毒应答时间≤7周,联合抗病毒治疗策略组患者总生存较病毒应答时间>7周,单药抗病毒治疗组患者可能提高,但是差异无统计学意义。结论:病毒应答时间较短的挽救性抗病毒治疗对于经免疫化疗后急性肝炎再活动的淋巴瘤患者可能具有一定治疗价值。

关 键 词:肝炎  乙型  淋巴瘤  拉米夫定  药物疗法

Efficacy of rescue antiviral therapy in lymphoma patients with acute exacerbations of hepatitis B after chemotherapy in combination with rituximab
DONG Min,WEI Li,LIN Qu,LI Xing,WEN Jing-yun,MA Xiao-kun,CHEN Zhan-hong,WU Xiangyuan.Efficacy of rescue antiviral therapy in lymphoma patients with acute exacerbations of hepatitis B after chemotherapy in combination with rituximab[J].Chinese Journal of Cancer Prevention and Treatment,2011,18(21):1717-1719.
Authors:DONG Min  WEI Li  LIN Qu  LI Xing  WEN Jing-yun  MA Xiao-kun  CHEN Zhan-hong  WU Xiangyuan
Institution:DONG Min,WEI Li,LIN Qu,LI Xing,WEN Jing-yun,MA Xiao-kun,CHEN Zhan-hong,WU Xiang-yuan Department of Medical Oncology,Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,P.R.China
Abstract:OBJECTIVE: To evaluate the role of rescue antiviral therapy in the treatment of acute exacerbations of hepatitis B after chemotherapy in combination with rituximab.METHODS: A retrospective study was conducted on the records of a total of 19 Chinese lymphoma patients who suffered this complication in order to characterize the rescue antiviral therapy.Receiver operating characteristic(ROC) analysis and Kaplan-Meier survival analysis were utilized to determine the potential superior antiviral strategy.RESULTS:...
Keywords:hepatitis B  lymphoma  lamivudine  drug therapy  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号